WHOLIHAN EDWARD (Chief Financial Officer) sold 36.1% of their position (68.55K shares) of ALLENA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $93.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2020ACC: 0000899243-20-034479
Officer· Chief Financial Officer
Since Mar 2019
-68.55K
Net shares
Net seller
$93.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
164.82K acquired · 233.37K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−68.55K
Price / share
$1.36
Trade value
$93.23K
% of position
36.1%
12/17/2020
189.82K→121.27K
Common Stock
Direct
Shares
+164.82K
Price / share
—
Trade value
—
% of position
659.3%
12/17/2020
25K→189.82K
Total
Net shares
+96.27K
Net value
-$93.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2020 | S · Sale | −68.55K | $1.36 | $93.23K | 36.1% | 189.82K | 121.27K |
| Common Stock Direct | 12/17/2020 | M · Option Exercise | +164.82K | — | — | 659.3% | 25K | 189.82K |
| Total | +96.27K | -$93.23K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
164.82K shares
Shares
−164.82K
Strike price
Held after
0.00
Exercisable
—
12/17/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock164.82K shares | 12/17/2020 | M · Option Exercise | −164.82K | — | 0.00 |